Prognosis
Pfizer Vaccine’s Funding Came From Berlin, Not Washington
- Partner BioNTech received $445 million from German government
- Operation Warp Speed agreed to buy vaccine doses if approved
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
It’s said that success has many authors, and the encouraging data from Pfizer Inc.’s experimental Covid-19 vaccine had plenty of people in Washington lining up to take credit.